Castle Biosciences, Inc. (CSTL)
NASDAQ: CSTL · Real-Time Price · USD
18.91
+0.37 (2.00%)
Jun 18, 2025, 4:00 PM - Market closed
Castle Biosciences Employees
Castle Biosciences had 761 employees as of December 31, 2024. The number of employees increased by 151 or 24.75% compared to the previous year.
Employees
761
Change (1Y)
151
Growth (1Y)
24.75%
Revenue / Employee
$456,088
Profits / Employee
-$6,661
Market Cap
545.98M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
CSTL News
- 2 days ago - Castle Biosciences Enters Collaboration and License Agreement with SciBase to Develop Diagnostic Tests for Dermatologic Diseases - GlobeNewsWire
- 8 days ago - Castle Biosciences' Chief Executive Officer Derek Maetzold to Participate in Panel Discussion During the 2025 BIO International Convention - GlobeNewsWire
- 15 days ago - Castle Biosciences' Founder, President and CEO Derek Maetzold Honored with Prestigious Lifetime Achievement Award by The American Business Awards® - GlobeNewsWire
- 20 days ago - New Data at ASCO 2025 Affirms DecisionDx®-Melanoma's Ability to Improve Upon Staging-Based Risk Stratification and Predict Survival Outcomes - GlobeNewsWire
- 4 weeks ago - Castle Biosciences to Present at the 2025 Jefferies Global Healthcare Conference - GlobeNewsWire
- 5 weeks ago - Real-World Study Confirms Long-Term Performance of DecisionDx®-UM for Metastatic Risk Stratification in Uveal Melanoma and Utility of PRAME Biomarker for Refining Risk When Considered with the DecisionDx-UM Class Result - GlobeNewsWire
- 6 weeks ago - Castle Biosciences Celebrates Skin Cancer Awareness Month - GlobeNewsWire
- 6 weeks ago - Castle Biosciences, Inc. (CSTL) Q1 2025 Earnings Call Transcript - Seeking Alpha